Teva Pharmaceuticals, Teva stocks down as stock price plunges
Teva, the world’s largest maker of life-saving chemotherapy drugs, reported disappointing earnings and revenue results for the first quarter, a major setback for its chief executive, who was replaced by former chief financial officer D.J. Haryana.The company posted a loss of $2.2 billion, or 31 cents a share, as its revenue fell by $2 billion.Analysts…